Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome.

Bellido F, Guinó E, Jagmohan-Changur S, Seguí N, Pineda M, Navarro M, Lázaro C, Blanco I, Vasen HF, Moreno V, Capellá G, Wijnen JT, Valle L.

Eur J Hum Genet. 2013 May;21(5):511-6. doi: 10.1038/ejhg.2012.204. Epub 2012 Sep 5.

2.

Combined analysis of three Lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriers.

Talseth-Palmer BA, Wijnen JT, Brenne IS, Jagmohan-Changur S, Barker D, Ashton KA, Tops CM, Evans TJ, McPhillips M, Groombridge C, Suchy J, Kurzawski G; Dutch Cancer Genetics Group, Spigelman A, Møller P, Morreau HM, Van Wezel T, Lubinski J, Vasen HF, Scott RJ.

Int J Cancer. 2013 Apr 1;132(7):1556-64. doi: 10.1002/ijc.27843. Epub 2012 Oct 11.

3.

DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome.

Reeves SG, Meldrum C, Groombridge C, Spigelman A, Suchy J, Kurzawski G, Lubinski J, Scott RJ.

Cancer Epidemiol. 2012 Apr;36(2):183-9. doi: 10.1016/j.canep.2011.09.003. Epub 2011 Oct 5.

PMID:
21974800
4.

Longer telomeres are associated with cancer risk in MMR-proficient hereditary non-polyposis colorectal cancer.

Seguí N, Guinó E, Pineda M, Navarro M, Bellido F, Lázaro C, Blanco I, Moreno V, Capellá G, Valle L.

PLoS One. 2014 Feb 3;9(2):e86063. doi: 10.1371/journal.pone.0086063. eCollection 2014.

5.

Germ-line variants identified by next generation sequencing in a panel of estrogen and cancer associated genes correlate with poor clinical outcome in Lynch syndrome patients.

Jóri B, Kamps R, Xanthoulea S, Delvoux B, Blok MJ, Van de Vijver KK, de Koning B, Oei FT, Tops CM, Speel EJ, Kruitwagen RF, Gomez-Garcia EB, Romano A.

Oncotarget. 2015 Dec 1;6(38):41108-22. doi: 10.18632/oncotarget.5694.

6.

Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.

ten Broeke SW, Brohet RM, Tops CM, van der Klift HM, Velthuizen ME, Bernstein I, Capellá Munar G, Gomez Garcia E, Hoogerbrugge N, Letteboer TG, Menko FH, Lindblom A, Mensenkamp AR, Moller P, van Os TA, Rahner N, Redeker BJ, Sijmons RH, Spruijt L, Suerink M, Vos YJ, Wagner A, Hes FJ, Vasen HF, Nielsen M, Wijnen JT.

J Clin Oncol. 2015 Feb 1;33(4):319-25. doi: 10.1200/JCO.2014.57.8088. Epub 2014 Dec 15.

PMID:
25512458
7.

Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome.

Wijnen JT, Brohet RM, van Eijk R, Jagmohan-Changur S, Middeldorp A, Tops CM, van Puijenbroek M, Ausems MG, Gómez García E, Hes FJ, Hoogerbrugge N, Menko FH, van Os TA, Sijmons RH, Verhoef S, Wagner A, Nagengast FM, Kleibeuker JH, Devilee P, Morreau H, Goldgar D, Tomlinson IP, Houlston RS, van Wezel T, Vasen HF.

Gastroenterology. 2009 Jan;136(1):131-7. doi: 10.1053/j.gastro.2008.09.033. Epub 2008 Sep 25.

PMID:
19010329
8.

Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.

Kloor M, Huth C, Voigt AY, Benner A, Schirmacher P, von Knebel Doeberitz M, Bläker H.

Lancet Oncol. 2012 Jun;13(6):598-606. doi: 10.1016/S1470-2045(12)70109-2. Epub 2012 May 1.

PMID:
22552011
9.

Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.

Lagerstedt Robinson K, Liu T, Vandrovcova J, Halvarsson B, Clendenning M, Frebourg T, Papadopoulos N, Kinzler KW, Vogelstein B, Peltomäki P, Kolodner RD, Nilbert M, Lindblom A.

J Natl Cancer Inst. 2007 Feb 21;99(4):291-9.

PMID:
17312306
10.

Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome.

Win AK, Clendenning M, Crawford W, Rosty C, Preston SG, Southey MC, Parry S, Giles GG, Macrae FA, Winship IM, Baron JA, Hopper JL, Jenkins MA, Buchanan DD.

Genes Cancer. 2015 Nov;6(11-12):445-51. Review.

11.

A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity.

Warden G, Harnett D, Green J, Wish T, Woods MO, Green R, Dicks E, Rahman P, Zhai G, Parfrey P.

Clin Genet. 2013 Dec;84(6):522-30. doi: 10.1111/cge.12080. Epub 2013 Feb 7.

PMID:
23278430
12.

Contribution of rare germline copy number variations and common susceptibility loci in Lynch syndrome patients negative for mutations in the mismatch repair genes.

Villacis RA, Miranda PM, Gomy I, Santos EM, Carraro DM, Achatz MI, Rossi BM, Rogatto SR.

Int J Cancer. 2016 Apr 15;138(8):1928-35. doi: 10.1002/ijc.29948. Epub 2015 Dec 28.

13.

Influence of methylenetetrahydrofolate reductase gene polymorphisms C677T and A1298C on age-associated risk for colorectal cancer in a caucasian lynch syndrome population.

Pande M, Chen J, Amos CI, Lynch PM, Broaddus R, Frazier ML.

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1753-9. Erratum in: Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2901.

14.

Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.

Goodfellow PJ, Billingsley CC, Lankes HA, Ali S, Cohn DE, Broaddus RJ, Ramirez N, Pritchard CC, Hampel H, Chassen AS, Simmons LV, Schmidt AP, Gao F, Brinton LA, Backes F, Landrum LM, Geller MA, DiSilvestro PA, Pearl ML, Lele SB, Powell MA, Zaino RJ, Mutch D.

J Clin Oncol. 2015 Dec 20;33(36):4301-8. doi: 10.1200/JCO.2015.63.9518. Epub 2015 Nov 9.

15.

Risk of pancreatic cancer in families with Lynch syndrome.

Kastrinos F, Mukherjee B, Tayob N, Wang F, Sparr J, Raymond VM, Bandipalliam P, Stoffel EM, Gruber SB, Syngal S.

JAMA. 2009 Oct 28;302(16):1790-5. doi: 10.1001/jama.2009.1529.

16.

Lynch or not Lynch? Is that always a question?

Colas C, Coulet F, Svrcek M, Collura A, Fléjou JF, Duval A, Hamelin R.

Adv Cancer Res. 2012;113:121-66. doi: 10.1016/B978-0-12-394280-7.00004-X. Review.

PMID:
22429854
17.

Lynch syndrome: a pediatric perspective.

Huang SC, Durno CA, Erdman SH.

J Pediatr Gastroenterol Nutr. 2014 Feb;58(2):144-52. doi: 10.1097/MPG.0000000000000179. Review.

PMID:
24051481
18.

Telomere length and genetic anticipation in Lynch syndrome.

Seguí N, Pineda M, Guinó E, Borràs E, Navarro M, Bellido F, Moreno V, Lázaro C, Blanco I, Capellá G, Valle L.

PLoS One. 2013 Apr 23;8(4):e61286. doi: 10.1371/journal.pone.0061286. Print 2013.

19.

Hereditary nonpolyposis colorectal cancer (HNPCC)/Lynch syndrome.

Steinke V, Engel C, Büttner R, Schackert HK, Schmiegel WH, Propping P.

Dtsch Arztebl Int. 2013 Jan;110(3):32-8. doi: 10.3238/arztebl.2013.0032. Epub 2013 Jan 18. Review.

20.

Evaluation of Lynch syndrome modifier genes in 748 MMR mutation carriers.

Houlle S, Charbonnier F, Houivet E, Tinat J, Buisine MP, Caron O, Benichou J, Baert-Desurmont S, Frebourg T.

Eur J Hum Genet. 2011 Aug;19(8):887-92. doi: 10.1038/ejhg.2011.44. Epub 2011 Mar 16.

Supplemental Content

Support Center